Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This review suggests that while platelet-rich plasma has the most robust clinical evidence, platelet-rich fibrin and concentrated growth factors are gaining favor due to their ease of use and absence of additives.

This study found that using intraoperative platelet-rich plasma in follicular unit extraction hair transplantation significantly improved graft survival, accelerated hair regrowth, and increased patient satisfaction compared to the procedure without PRP.

The study concluded that the Exprecell™ device for preparing anticoagulant-free f-PRF increases volume yield and simplifies the process while maintaining biological activity comparable to conventional methods, suggesting potential clinical utility.

This case report details a 28-year-old male with early-stage androgenetic alopecia who experienced significant hair density and thickness improvements following a three-month platelet-rich plasma therapy regimen, supporting its potential efficacy in similar cases.

In this case report, a 28-year-old male with androgenetic alopecia experienced significant improvement in hair density and shaft thickness after a three-month platelet-rich plasma therapy regimen, supporting existing literature on PRP's efficacy for early-to-moderate hair loss.

In this study, platelet-rich plasma injections in mice were associated with faster hair growth and increased expression of the Wnt10b protein in hair follicles, suggesting potential benefits for treating alopecia.

This review discusses the current evidence on platelet-rich plasma therapy's biological mechanisms and clinical applications, highlighting its promise in regenerative medicine and the challenges to its integration in nursing practice.

This review covers the application of platelet-rich plasma therapy across multiple medical fields, noting its widespread use and safety but also highlighting the need for further research.

This study found that injecting PRP gel derived from a patient's own blood may promote tissue regeneration and closure of intestinal fistulas unresponsive to conservative therapy.

This study found that platelet-rich plasma significantly improved hair density and facial texture in non-surgical aesthetic treatments and reported it as an effective and safe option for androgenic alopecia and facial rejuvenation.

This clinical trial conducted at Zagazig University found that minoxidil mesotherapy achieved more significant improvements in alopecia grade, hair thickness, and terminal hair count compared to PRP in adults with androgenetic alopecia, with higher patient satisfaction and less pain reported in the minoxidil group.

This article reviews the regenerative benefits of platelet-rich plasma in various medical fields, particularly in dermatology and aesthetic medicine, without presenting new clinical data.

This study found that a motion-graphic educational video significantly improved patient knowledge during the informed consent process for platelet-rich plasma therapy in androgenetic alopecia compared to traditional verbal explanations, without affecting anxiety levels, and participants reported high satisfaction with the video.

This case report observed marked hair regrowth in a patient with refractory alopecia areata using a combination of platelet-rich plasma, low-level light therapy, and microneedling alongside topical and oral agents.

This study found that platelet-rich plasma therapy significantly improved hair density, diameter, and reduced inflammation in androgenetic alopecia patients compared to placebo, though individual responses varied.

This randomized controlled trial found that adding Platelet-Rich Plasma to Direct Hair Implantation significantly improved hair growth rate and follicle density in patients with androgenetic alopecia.

This study found that platelet-rich plasma therapy may improve hair density and thickness in androgenetic alopecia, especially in early to moderate stages, though standardization of preparation is needed for consistent results.

This review discusses the evidence for platelet-rich plasma as a promising treatment for androgenetic alopecia, highlighting its potential benefits and favorable safety profile but noting the need for standardized protocols and larger trials.

This review synthesizes existing research on autologous platelet-rich plasma for treating androgenetic alopecia, suggesting its promise with standardized protocols and personalized approaches, but reports no new clinical results.

This review reports that while platelet-rich plasma shows promise as a safe treatment for various types of hair loss, variability in studies limits definitive conclusions on its effectiveness.

In this systematic review and meta-analysis, the authors found that platelet-rich plasma improves hair density and facial texture with no serious adverse effects in non-surgical aesthetic treatments.

This study found that both intralesional corticosteroids (TAC) and platelet-rich plasma (PRP) are effective for treating patchy alopecia areata, with TAC providing faster early results but PRP offering better long-term safety and lower relapse rates.

This study found that combining platelet-rich plasma with topical minoxidil was safe and significantly improved hair density and quality of life in patients experiencing chronic hair fall.

This study reviews current methods for making and using platelet-rich plasma and fibrin, emphasizing the variability in clinical outcomes due to differences in preparation protocols, and calls for standardized guidelines and large-scale studies for better effectiveness in regenerative medicine.

This study bibliometrically evaluated 5741 articles on PRP from 1980 to 2024, highlighting Türkiye's contribution and identifying prominent research areas such as orthopedics and wound healing.

This review found that platelet-rich plasma therapy may enhance ovarian repair and fertility outcomes in ovarian insufficiency, but notes that optimal usage and long-term effects require further investigation.

This study critically reviewed recent evidence (2020–2025) on treatments like platelet-rich plasma, photobiomodulation, stem cells, and exosomes for androgenetic alopecia, finding emerging but limited efficacy data and emphasizing the need for standardized protocols to enhance transparency and patient safety.

This review synthesizes evidence supporting the efficacy of PRP in dermatological conditions like wound healing and alopecia, but emphasizes the need for standardized protocols and larger randomized controlled trials.

This study found that platelet-rich plasma therapy led to greater improvements in hair density and patient satisfaction compared to topical 5% Minoxidil in androgenetic alopecia patients over 12 weeks.

In this case report, PRP therapy led to almost complete clearance of hypopigmentation in a 28-year-old Caucasian female after laser hair removal, suggesting PRP could be a promising treatment option for various hypopigmentation conditions.